Friday December 15th 2017

Life Threatening Asthmatic Crisis After 6 Months Of Fingolimod Treatment (P2.225)

Conclusion: The patient with asthmatic hyper-reactivity in her youth developed a serious respiratory adverse event after 6 months of FTY therapy. Published data show rather transitory worsening of the pulmonary function occurring within one month after FTY start both in MS and non-MS moderately asthmatic patients. Based on its mechanism of action, FTY might have precipitated bronchoconstriction in this case even in the long term.Disclosure: Dr. Caporro has nothing to disclose. Dr. Gobbi has received personal compensation for activities with Teva Neuroscience, Merck Serono, Biogen Idec, Bayer Schering, Novartis, and Genzyme Corp. as a consultant. Dr. Chiara has received personal compensation for activities with Teva Neuroscience, Merck & Co. Inc., Biogen Idec, Bayer Pharmaceuticals Corp…

View article: 

Life Threatening Asthmatic Crisis After 6 Months Of Fingolimod Treatment (P2.225)

Leave a Comment

More from category

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]

Scientists discover blood sample detection method for multiple sclerosis
Scientists discover blood sample detection method for multiple sclerosis

(University of Huddersfield) Researchers identified two natural biomarker compounds present in the blood. (Source: [Read More]

Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s
Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s

(Natural News) Parkinson’s disease is the second most common neurodegenerative disease plaguing people today, with an [Read More]